New Thrombolytic Infusion Application of Dissolving Renal Artery Embolic Thrombosis: Low-Dose Slow-Infusion Thrombolytic Therapy [PDF]
Renal artery thromboembolism (RATE) is an uncommon complication of renal arteries from heart chamber. Although there is no treatment protocol prescribed with guidelines, thrombolytic agents such as rt-PA are frequently used.
Ahmet Karakurt
doaj +2 more sources
Initial Results of Oral Thrombolytic Agent Clinical Application [PDF]
At the moment, there is no oral thrombolytic drug on the world pharmaceutical market. The drug Trombovazim, which has a thrombolytic effect under oral administration, has been registered in Russia. It differs from all thrombolytics—it has a fundamentally
Pavel Madonov +5 more
doaj +2 more sources
CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION [PDF]
Aim. To evaluate the clinical results of thrombolytic therapy with thrombolytics (alteplase, tenecteplase) in patients with ST segment elevation myocardial infarction (STEMI). Material and methods.
L. A. Bondarenko +4 more
doaj +5 more sources
The search for the ideal thrombolytic agent [PDF]
Since streptokinase and urokinase became available for clinical use, numerous attempts have been made to improve these useful thrombolytic agents. To decrease its antigenicity, streptokinase has been fragmented or coupled to human plasminogen or polyethylene glycols. With a plasmin B chain-streptokinase complex a more potent agent was obtained.
Marc Verstraete, Verstraete, Marc
openaire +3 more sources
Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future? [PDF]
Purpose of review: Alteplase has been the thrombolytic of choice for acute ischaemic stroke for more than two decades. A thrombolytic which is easier to administer and with improved or comparable safety and efficacy is desirable.
Mahmood A, Muir KW.
europepmc +3 more sources
Thrombolytic protease characterization from leaves and fruit flesh of the jernang rattan plant (Daemonorops draco) [PDF]
Thrombolytic agents are used for thrombolytic therapy to dissolve blood clots that form in a blood vessel. All currently used thrombolytic agents have unfavorable shortcomings, such as gastrointestinal bleeding, allergic reactions, and thrombolytic agent
Urbanus Yustus Lebuan +3 more
doaj +2 more sources
GC-MS analysis, evaluation of phytochemicals, anti-oxidant, thrombolytic and anti-inflammatory activities of Exacum bicolor [PDF]
The aim of the present study was to investigate the GC-MS analysis, phytochemical screening, anti-oxidant, thrombolytic and anti-inflammatory activities of methanol extract of leaves of Exacum bicolor.
Appaji Mahesh Ashwini +3 more
doaj +2 more sources
Clinical trial of fibrinselective thrombolytic pharmaceutical agent «FORTELYZIN®» (III Phase) [PDF]
The clinical trial of fibrinselective thrombolytic agent Fortelyzin® (III phase) showed the comparative efficacy and safety with Actilyse® in patients with acute myocardial infarction and obtained data permitted to recommend it for clinical usage.
S S Markin +5 more
doaj +1 more source
Comparative Analysis of Therapeutic Efficacy and Adverse Reactions among Various Thrombolytic Agents [PDF]
Thrombosis is a major health concern that contributes to the development of several cardiovascular diseases and a significant number of fatalities worldwide.
Chenxi Xie +9 more
doaj +2 more sources
Total Thiols and MDA Levels in Patients with Acute Myocardial Infarction Before and After Reperfusion Therapy [PDF]
Background: Reactive oxygen species have been implicated in the pathogenesis of ischemic and reperfusion injury. In the current work we have measured malondialdehyde (MDA), total thiols, total CK, CK-MB and AST in ECG proven acute myocardial infarction ...
Suresh Babu +2 more
doaj +1 more source

